From: Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379]
Adverse effect | Gabapentin (N = 54) n (%) | Placebo (N = 51) n(%) | Significance |
---|---|---|---|
Dizziness | 20 (37.3) | 2 (3.9) | P = 0.0000 |
Somnolence | 15 (27.8) | 3 (5.9) | P = 0.003 |
Lethargy | 11 (20.4) | 1 (2.0) | P = 0.003 |
Nausea | 10 (18.5) | 5 (9.8) | n.s. |
Headache | 8 (14.8) | 3 (5.9) | n.s. |
Stomach problems | 4 (7.4) | 3 (5.9) | n.s. |
'drunken' | 4 (7.4) | 0 (0) | n.s. |
Disturbed gait | 4 (7.4) | 0 (0) | n.s. |
Water retention | 1 (1.9) | 3 (5.9) | n.s. |